New whitepaper: Toward outcomes-based payments 
The push to generate evidence and demonstrate value for healthcare provider value
In this new report from Reuters Events Pharma, in partnership with Optum, market access and value leaders give their insights on how to generate evidence and demonstrate value for HCP value.
Learn from these senior market access and value leaders:
You will discover how to: 
  • Overcome challenges to ensure outcomes-based contracts become the default standard for negotiation with payers
  • Generate evidence early to demonstrate overall efficacy and individual patient outcomes, including common scenarios for an outcomes-based contract
  • Accelerate adoption to provide the right therapies to the right patient at the right time, improving quality of life while reducing the long-term cost of care.
Please don’t hesitate to reach out with any questions or thoughts. 
Kind regards,

Download this 12+ page whitepaper below
With insights from market access and value leaders at Novartis Gene Therapies, Lilly Oncology, EMD Serono and more… 
Reuters Events will use this information to contact you about relevant content, products, and services. You may unsubscribe at any time. For more information, check out our Privacy Policy:
Please tick this box to give Reuters Events permission to provide my contact information to Optum - - so Optum can share the latest Optum news and offers with me by email or telephone.
You may unsubscribe from receiving news and offers from the sender at any time by following the instructions in the communications received. Optum handles your information as described in the Optum Privacy Notice -

Reuters Events is part of Reuters News & Media Ltd, 5 Canada Square, Canary Wharf, London, E14 5AQ. Registered in England and Wales: 2505735.